Your browser doesn't support javascript.
loading
Post-hepatectomy venous thromboembolism: a systematic review with meta-analysis exploring the role of pharmacological thromboprophylaxis.
Karunakaran, Monish; Kaur, Ramneek; Ismail, Simi; Cherukuru, Sushma; Jonnada, Pavan Kumar; Senadhipan, Baiju; Barreto, Savio George.
Afiliação
  • Karunakaran M; Department of Surgical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
  • Kaur R; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Ismail S; Department of Anesthesiology, Institute of Liver Transplantation & Regenerative Medicine, Medanta-The Medicity, Gurugram, India.
  • Cherukuru S; Department of Radiology, KIMS Hospital, Thiruvananthapuram, India.
  • Jonnada PK; Department of Pathology, ESI Hospital, Hyderabad, India.
  • Senadhipan B; Department of Surgical Oncology, Basavatarakam Indo-American Cancer Hospital & Research Institute, Hyderabad, India.
  • Barreto SG; Department of Surgical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
Langenbecks Arch Surg ; 407(8): 3221-3233, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35881311
ABSTRACT

PURPOSE:

Patients undergoing hepatectomy are at moderate-to-high risk of venous thromboembolism (VTE). This study critically examines the efficacy of combining pharmacological (PTP) and mechanical thromboprophylaxis (MTP) versus only MTP in reducing VTE events against the risk of hemorrhagic complications.

METHODS:

A systematic review of major reference databases was undertaken, and a meta-analysis was performed using common-effects model. Risk of bias assessment was performed using Newcastle-Ottawa scale. Trial sequential analysis (TSA) was used to assess the precision and conclusiveness of the results.

RESULTS:

8 studies (n = 4238 patients) meeting inclusion criteria were included in the analysis. Use of PTP + MTP was found to be associated with significantly lower VTE rates compared to only MTP (2.5% vs 5.3%; pooled RR 0.50, p = 0.03, I2 = 46%) with minimal type I error. PTP + MTP was not associated with an increased risk of hemorrhagic complications (3.04% vs 1.9%; pooled RR 1.54, p = 0.11, I2 = 0%) and had no significant impact on post-operative length of stay (12.1 vs 10.8 days; pooled MD - 0.66, p = 0.98, I2 = 0%) and mortality (2.9% vs 3.7%; pooled RR 0.73, p = 0.33, I2 = 0%).

CONCLUSION:

Despite differences in the baseline patient characteristics, extent of hepatectomy, PTP regimens, and heterogeneity in the pooled analysis, the current study supports the use of PTP in post-hepatectomy patients (grade of recommendation strong) as the combination of PTP + MTP is associated with a significantly lower incidence of VTE (level of evidence, moderate), without an increased risk of post-hepatectomy hemorrhage (level of evidence, low).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa Idioma: En Ano de publicação: 2022 Tipo de documento: Article